4.6 Article

Murine B Cells Regulate Serum IgE Levels in a CD23-Dependent Manner

Journal

JOURNAL OF IMMUNOLOGY
Volume 185, Issue 9, Pages 5040-5047

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1001900

Keywords

-

Categories

Funding

  1. National Institutes of Health [AI026918, AI078869]
  2. National Institute of Child Health and Human Development [HD044331]
  3. American Academy of Allergy, Asthma and Immunology/Glaxo SmithKline
  4. A.P. Giannini Medical Research Foundation
  5. Howard Hughes Medical Institute

Ask authors/readers for more resources

The manifestations of allergic disorders are closely tied to the biologic effects of IgE activation with Ag. In immediate hypersensitivity reactions, IgE effector function requires prior binding to innate immune cells, primarily mast cells and basophils, with the blood acting as a reservoir for unbound IgE. As the severity of allergic disease is proportional to the size of this unbound IgE pool, we hypothesized that cellular mechanisms exist to limit the size and/or enhance the clearance of free IgE molecules. We examined this in mice by engineering a reporter IgE molecule that allowed us to track the fate of IgE molecules in vivo. The absence of Fc epsilon RI-expressing cells did not affect serum IgE levels, but B cells regulated serum IgE by controlling the size of the free IgE pool. B cells captured IgE by direct binding to the low-affinity IgE receptor, CD23. These data indicate a mechanism regulating serum IgE and additionally clarify the role of CD23 in this process. The Journal of Immunology, 2010, 185: 5040-5047.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available